3 Agents to Watch for Decompensated Cirrhosis from NASH
HepaStem, BIV201, and Albutein are late-stage pipeline agents in development for NASH, focusing specifically on decompensated cirrhosis.
United States John Tchelingerian Sravani Meka Sandra Camprubi Promethera Group Acute On Chronic Liver Failure
Source: hcplive.com